🧬 Aging Wiki

smad2-smad3

Properties1
aliasesSMAD2, SMAD3, MADH2, MADH3, MADR2, hSMAD2, hSMAD3, R-SMAD, receptor-regulated SMAD

8 min read

SMAD2 / SMAD3 (paralog pair)

SMAD2 and SMAD3 are the two receptor-regulated SMADs (R-SMADs) activated downstream of TGF-β and activin receptors. They are the primary cytoplasmic transducers of TGF-β superfamily signaling: phosphorylated at the C-terminal SXS motif by type I receptors (ALK4/5/7), they oligomerize with the common-mediator smad4 and translocate to the nucleus as transcriptional regulators. In aging biology, elevated pSMAD3 in aged muscle satellite cells suppresses their regenerative capacity and represents one of the best-characterized molecular mechanisms linking the aged systemic environment to impaired tissue repair 1.

Identity

FieldSMAD2SMAD3
UniProtQ15796P84022
Gene symbolSMAD2SMAD3
Gene synonymsMADH2, MADR2MADH3
HGNCHGNC:6768HGNC:6769
NCBI Gene40874088
EnsemblENSG00000175387ENSG00000166949
Length (canonical)467 aa425 aa
Mouse orthologSmad2Smad3
ClassR-SMAD (TGF-β/activin branch)R-SMAD (TGF-β/activin branch)

Both are human paralogs with ~87% sequence identity in the MH2 domain. The key structural divergence is in the MH1 domain (see below).

Domain architecture

Both proteins share the canonical two-domain SMAD architecture with a disordered linker region 2:

[MH1]---[linker]---[MH2]

MH1 domain (N-terminal)

  • SMAD3 — directly binds the SMAD-binding element (SBE; consensus CAGAC) in gene promoters. Contains a conserved beta-hairpin DNA-contact loop.
  • SMAD2 — a unique exon 3 insertion of ~30 amino acids (encoded by exon 3) is inserted into the MH1 domain and blocks the beta-hairpin loop from contacting DNA directly. SMAD2 therefore cannot bind SBE DNA independently; it requires partner transcription factors for promoter engagement 3.
  • Both MH1 domains mediate nuclear import and interaction with SARA (SMAD-anchor for receptor activation).

Linker region

  • Intrinsically disordered; contains a PY motif recognized by HECT E3 ubiquitin ligases (SMURF1/2 → targeted degradation).
  • Contains CDK8/9 phosphorylation sites that modulate transcriptional activity and SMURF-mediated turnover in a context-dependent manner.

MH2 domain (C-terminal)

  • Mediates receptor interaction, homo/hetero-oligomerization with smad4, and interaction with transcriptional co-activators / co-repressors.
  • Contains the C-terminal SXS activation motif: Ser-Met-Ser (Ser-465/Ser-467 in SMAD2; Ser-423/Ser-425 in SMAD3). Phosphorylation at both serines is required for activation.
  • ~87% identical between SMAD2 and SMAD3.

Receptor activation and nuclear translocation

The canonical activation cycle 3 2:

  1. Ligand binding — TGF-β1/2/3 (or activins) bind the TGF-β receptor II (TGFBR2) ectodomain and recruit type I receptors (ALK4 for activin, ALK5 for TGF-β, ALK7 for nodal/GDF).
  2. GS domain phosphorylation — TGFBR2 transphosphorylates ALK5 in its GS (glycine-serine-rich) domain, activating the ALK5 kinase.
  3. R-SMAD phosphorylation — Active ALK5 directly phosphorylates the SXS motif at the R-SMAD C-terminus, releasing SMAD2/3 from the anchoring protein SARA.
  4. Heterotrimer assembly — Phosphorylated SMAD2 or SMAD3 binds smad4 (2:1 ratio, one SMAD4 per two R-SMADs). The active nuclear complex is a heterotrimer.
  5. Nuclear import — The SMAD2/3–SMAD4 complex translocates to the nucleus, primarily via importin-β3 (IPO7 for SMAD2).
  6. Transcriptional regulation — Nuclear SMAD3 directly contacts SBE sequences; SMAD2 requires partner TFs (FOXH1, FAST/FoxA, RUNX, AP-1 family) for gene-specific targeting. Target gene sets depend on cell type and co-factor availability.
  7. Nuclear export and reset — Dephosphorylation of SXS by PPM1A (SMAD2) or RANBP3-facilitated nuclear export (SMAD3) recycles the complex to the cytoplasm.

SMAD2 vs SMAD3: functional non-redundancy

Despite high sequence identity, the two paralogs are not functionally interchangeable in vivo 3:

  • SMAD2 — principal mediator of embryonic patterning (mesoderm/endoderm induction, left-right axis). SMAD2-null mice die at gastrulation (E7.5–8.5). Primarily regulates the TGF-β transcriptional response in contexts requiring partner TF co-binding.
  • SMAD3 — more prominent role in postnatal wound healing, fibrosis, immune modulation, and the adult stem-cell niche. SMAD3-null mice are viable, fertile, and develop normally but show impaired TGF-β-mediated growth inhibition and altered immune responses.
  • In aged satellite cells, pSMAD3 (not pSMAD2) is the dominant elevated species, and SMAD3-specific CDK inhibitor targets (p15, p16, p21, p27) are the downstream effectors of the aging phenotype 1.

Aging biology

Elevated pSMAD3 impairs aged satellite cell regeneration

The defining aging-biology finding for SMAD2/3 is Carlson et al. 2008 (Nature): aged skeletal muscle exhibits elevated TGF-β/pSMAD3 signaling in satellite cells, and this excess pSMAD3 drives upregulation of CDK inhibitors (p15, p16, p21, p27), locking satellite cells in a quiescence from which they fail to properly exit upon injury 1.

Key mechanistic details:

  • Notch signaling and pSMAD3 normally antagonize each other: active Notch signaling restricts pSMAD3 target-gene access to CDK inhibitor promoters. In aged muscle, reduced Notch activation allows pSMAD3 to unopposed bind these loci.
  • ALK5 inhibitor treatment in aged injured muscle restored satellite cell activation and regenerative output in vivo in mice. needs-human-replication
DimensionStatusNotes
Pathway conserved in humans?yesTGF-β/SMAD3 pathway is conserved; human satellite cells express ALK5/SMAD3
Phenotype conserved in humans?partialCarlson 2009 (EMBO Mol Med) showed elevated pSMAD3 in 70-year-old human satellite cells
Replicated in humans?in-progressHuman satellite cell data exists 4; pharmacological intervention not yet tested in humans

Elevated systemic TGF-β1 with age amplifies SMAD3 signaling

Serum TGF-β1 levels rise with age in mice, and this elevated systemic TGF-β contributes to pSMAD3 elevation in satellite cells beyond what local muscle TGF-β explains 5. Wnt signaling (another systemic age-increase factor) does not appear to contribute additively in this context. needs-replication — mechanistic framing based primarily on Carlson et al. experiments; independent confirmation needed.

SMAD3 and satellite cell quiescence maintenance

Beyond the aging context, SMAD3 is required for maintaining satellite cell quiescence in young adult muscle 3. unsourced — a dedicated primary citation for the quiescence-maintenance claim is needed beyond the general Massagué review; see [[tgf-beta]] for additional context.

Paracrine pSMAD3 signaling and the aged niche

The aged systemic milieu (elevated circulating TGF-β1, GDF11 [contested — see [[gdf11]] contradictory-evidence), and possibly myostatin/GDF8 from senescent muscle fibers) constitutes a paracrine input that keeps satellite cells in a pSMAD3-high state. This is part of the broader altered-intercellular-communication hallmark and overlaps with the concept of “niche aging” driving stem-cell-exhaustion.

Disease associations

  • Loeys-Dietz syndrome 6 (LDS6) — caused by heterozygous loss-of-function mutations in SMAD2 (pathogenic variants at UniProt Q15796). Phenotype includes aortic aneurysms/dissection, arterial tortuosity, craniofacial anomalies. Mechanistically: deficient TGF-β signaling in vascular smooth muscle.
  • Loeys-Dietz syndrome 3 (LDS3) — caused by heterozygous SMAD3 mutations (P84022). Similar vascular phenotype; also associated with early-onset osteoarthritis.
  • Cancer — In most epithelial tumors, TGF-β is tumor-suppressive early (cytostatic via SMAD3–p15 axis) but switches to tumor-promoting late (via SMAD-independent branches promoting invasion/metastasis). SMAD2/3 LoF mutations occur at low frequency in colorectal and pancreatic cancers; more commonly, the TGF-β pathway is disrupted via smad4 LoF (which aborts all R-SMAD signaling). SMAD2/3 are therefore rarely the rate-limiting lost nodes in cancer.
  • tgf-beta — canonical upstream pathway; R20 Reactome entry R-HSA-170834.
  • bmp-signaling — the BMP arm of the TGF-β superfamily uses SMAD1/5/8 (not SMAD2/3) as its R-SMADs, activated by ALK1/2/3/6. SMAD2/3 are not directly activated by BMP ligands. Cross-talk occurs via shared smad4 and co-regulator competition.
  • satellite-cells — primary cell type for aging-biology claims on this page.
  • smad4 — obligate heterotrimer partner; loss of SMAD4 abrogates all SMAD2/3 nuclear signaling.
  • sarcopenia — likely downstream consequence of impaired satellite cell regeneration via pSMAD3 excess in aged muscle.

Key interactors

  • ALK5 (TGFBR1) — the kinase that directly phosphorylates the SXS motif; the upstream activator.
  • TGFBR2 — ligand-binding receptor that recruits and activates ALK5.
  • smad4 — obligate nuclear co-factor; forms 2:1 R-SMAD:SMAD4 heterotrimer.
  • SARA (SMAD-anchor for receptor activation; ZFYVE9) — tethers inactive SMAD2/3 near the receptor at the membrane.
  • SMURF1/SMURF2 — HECT E3 ligases that ubiquitinate the PY motif in the linker → proteasomal degradation (negative feedback).
  • PPM1A — C-terminal phosphatase that dephosphorylates the SXS motif, resetting the signaling cycle.
  • NOTCH pathway (via NICD) — antagonizes pSMAD3 chromatin access at CDK inhibitor loci; critically important in the aged satellite cell context 1.
  • FOXH1, RUNX2/3, AP-1 — partner TFs that enable SMAD2 (DNA-binding-deficient) to reach specific promoters.

Limitations and gaps

  • needs-canonical-id — SMAD3 NCBI Gene ID (4088) confirmed from HGNC cross-reference; the brief listed ncbi-gene as 4087 for the pair (SMAD2 only). SMAD3 Ensembl ID (ENSG00000166949) was not independently confirmed via the UniProt API in this session — verify on next pass.
  • needs-human-replication — ALK5 inhibitor rescue of satellite cells demonstrated in aged mice only; no human pharmacological trial data available as of 2026-05-05.
  • needs-replication — The “Notch antagonizes pSMAD3 chromatin access” mechanism (Carlson 2008) is from a single Nature study; independent mechanistic confirmation is limited.
  • unsourced — SMAD3 quiescence-maintenance role in young satellite cells needs a dedicated primary citation (beyond the Massagué 2000 general review).
  • no-mechanism — The switch from SMAD2-dominance in embryogenesis to SMAD3-dominance in adult tissue homeostasis and aging is not mechanistically understood at the chromatin level.
  • contradictory-evidence — GDF11 (a related TGF-β superfamily ligand) was reported to be elevated with age and rejuvenate aged satellite cells; this has been extensively contested. See [[gdf11]].
  • genage-id: null — Neither SMAD2 nor SMAD3 appears in GenAge-human as of 2026-05-05; relevant models-organism lifespan data not found. Tag if a GenAge entry is later identified.
  • druggability-tier: null — No Open Targets Platform entry checked; ALK5 (TGFBR1) is the more-druggable upstream node. Set no-opentargets-entry until checked.

Footnotes

Footnotes

  1. carlson-2008-psmad3-notch-satellite-cells · n=not specified (multiple cohorts, young vs aged mice) · in-vivo + in-vitro · model: aged C57BL/6 mice + human satellite cells · doi:10.1038/nature07034 · locally available ↩ ↩2 ↩3 ↩4

  2. heldin-1997-tgfbeta-smad-signalling · review · Nature · doi:10.1038/37284 · 3677 citations; PDF not locally available (closed access) ↩ ↩2

  3. massague-2000-tgfbeta-cells-read-signals · review · Nat Rev Mol Cell Biol · doi:10.1038/35043051 · locally available ↩ ↩2 ↩3 ↩4

  4. carlson-2009-human-muscle-stem-cell-aging · in-vitro + ex-vivo · model: human satellite cells (20-year-old vs 70-year-old donors) · doi:10.1002/emmm.200900045 · download pending ↩

  5. carlson-2009-tgfbeta-wnt-satellite-cell-aging · in-vivo · model: aged C57BL/6 mice · doi:10.1111/j.1474-9726.2009.00517.x · download pending ↩

Graph View

Backlinks